FDA advisors back GlaxoSmithKline RSV vaccine for older adults ...Middle East

The Hill - News
FDA advisors back GlaxoSmithKline RSV vaccine for older adults
A Food and Drug Administration (FDA) advisory panel on Wednesday recommended the second vaccine for respiratory syncytial virus (RSV) in older adults in as many days, setting up a race between manufacturers looking to bring the first-of-its-kind shot to market. The 12-member panel voted 10-2 that the vaccine developed by GlaxoSmithKline is safe, and separately voted unanimously that data show the shot is effective. Similar to data presented Tuesday for a vaccine manufactured by Pfizer, some panel members had concerns about nervous system disorders like Guillain-Barré syndrome that may be tied to the shot.   "For a vaccine that could be potentially recommended every year for every

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA advisors back GlaxoSmithKline RSV vaccine for older adults )

Also on site :